References
- Brown R. D., Manno J. E. J. Pharm. Sci. 1978; 67: 1687
- Proost J. H. J. Pharm. Sci. 1985; 74: 793
- Notari R. E., De Young J. L., Anderson R. C. Biopharmaceutics and Pharmacokinetics: An Introduction, 2nd ed. Dekker, New York 1975; 18–24
- Gibaldi M., Perrier D. Pharmacokinetics. Dekker, New York 1975; 89–95
- Perrier D., Mayersohn M. J. J. Pharm. Sci. 1982; 71: 372
- , The tetracycline and haloperidol data from Ref. 1 constituted the first data set. The fenoximone and the fenoximone sulfoxide plasma concentration data from Ref. 12 were used for the second and third data sets. The fourth set contained data from three sources (Refs. 13, 14, and 15)
- Statistical Analysis System (SAS). SAS Institute Inc., Cary, North Carolina, Release 82.4, Box 8000
- Cambridge, MA, LOTUS 123 release 1A, Lotus Development Corp., 161 First Street
- Benet L. Z., Galeazzi R. L. J. Pharm. Sci. 1979; 68: 1071
- Ritschel W. A. Handbook of Basic Pharmacokinetics, 2nd ed. Drug Intelligence Publications, Hamilton, IL 1980; 375–377
- Evans W. E., Schentag J. J., Jusko W. J. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Applied Therapeutics, San Francisco 1980; 639–680
- Aiken R. G., Belz G. G., Haegele K. D., Meinicke T., Schechter P. Clin. Pharmacol. Ther. 1984; 36: 209
- Snedecor G. W., Cochran W. G. Statistical Methods, 6th ed. The Iowa State University Press, Ames 1967; 95, Table 4.3.1
- Sokal R. R., Rohlf F. J. Biometry: The Principles and Practice of Statistics in Biological Research. W. H. Freeman, San Francisco 1969; 51, Table 4.1
- Zar J. H. Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, NJ 1974; 32, Example 4.2, Samples 1 and 2